Dr. Kenneth J. Pienta is the Donald S. Coffey Professor of Urology and professor of oncology and pharmacology and molecular sciences at the Johns Hopkins University School of Medicine. He is a two-time American Cancer Society Clinical Research Professor Award recipient. He serves as the director of research for the Brady Urological Institute. Opened in January 1915, the Brady Urological Institute was the only one of its kind in the country. It was the No. 1 urological institute in the United States for 21 years in a row (1991 – 2011). Dr. Pienta was the associate vice president for research, health sciences, for the University of the Michigan from 2012 to 2013 and director of precision medicine for the Michigan Center for Translational Pathology from 2008 to 2013.
Currently Dr. Pienta is involved in research to define the tumor microenvironment of prostate cancer metastases, as well as developing new therapies for prostate cancer. Between 1995 and 2013, Dr. Pienta was the director of the Prostate Specialized Program of Research Excellence at the University of Michigan. He has a proven, peer-reviewed track record in organizing and administering a translational research program that successfully incorporates bench research, agent development and clinical application. Dr. Pienta has international expertise in the development of novel chemotherapeutic programs for prostate cancer and has championed the concept that translational research is often best accomplished by multidisciplinary teams of scientists and clinicians. Under his direction, the success of these endeavors led to the receipt of the 2007 first annual American Association for Cancer Research Team Science Award. He is the author of more than 350 peer-reviewed articles and been the principal investigator on numerous local and national clinical trials. Throughout his career, Dr. Pienta has effectively mentored more than 40 students, residents and fellows to successful careers in medicine.